InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,387.45
(
0.81%
)
US TECH 100
18,309.60
(
1.41%
)
Dow Jones
39,446.08
(
0.23%
)
Brent Oil
80.86
(
-0.92%
)
Bitcoin
59,626.87
(
0.46%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

rocky301

Send PM Follow Ignore
Followers 110
Posts 6480
Boards Moderated 0
Alias Born 05/01/2003

rocky301

Re: astockalypse post# 21566

Wednesday, 01/06/2010 3:07:31 PM

Wednesday, January 06, 2010 3:07:31 PM

Post# of 92948
dew,


fwiw,

they PR'd the FDA filing on Thursday Nov 19th, the clip below indicates it was filed on the 18th, Wednesday. Using the 19th as the starting count and ending with tomorrow, the 7th, as you stated would put us at 50 days. Nov. 12 days, Dec. 31 days, Jan. 7 days..


"Lanza said ACT decided to target Stargardt’s macular dystrophy first because it has been designated an “orphan disease” and could benefit from a faster regulatory review. The FDA has 30 days to respond to the company’s filing, made Wednesday, and the clinical trial could begin early next year."
http://latimesblogs.latimes.com/booster_shots/2009/11/human-embyronic-stem-cells-stargardts-macular-dystrophy.html
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up